<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0074">
 <label>74</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Leclerc</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Garnier</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hoessel</surname>
    <given-names>R</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer’s disease. A property common to most cyclin-dependent kinase inhibitors?</article-title>
  <source>J Biol Chem</source>
  <year>2001</year>;
  <volume>276</volume>:
  <fpage>251</fpage>–
  <lpage>60</lpage>.
  <pub-id pub-id-type="pmid">11013232</pub-id>
 </mixed-citation>
</ref>
